Global Bronchopulmonary Dysplasia Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 93

Report ID: 1812

Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.
The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period.
In 2018, the global Bronchopulmonary Dysplasia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Bronchopulmonary Dysplasia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bronchopulmonary Dysplasia development in United States, Europe and China.

The key players covered in this study
Chiesi Farmaceutici
Discovery Laboratories
Takeda Pharmaceutical Company
MediPost
Clarassance
Syntrix Biosystems
...

Market segment by Type, the product can be split into
Surfactant Replacement Therapy
Oxygen Therapy
Supportive Therapy
Others

Market segment by Application, split into
Clinic
Hospital
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Bronchopulmonary Dysplasia status, future forecast, growth opportunity, key market and key players.
To present the Bronchopulmonary Dysplasia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Bronchopulmonary Dysplasia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type (2014-2025)
1.4.2 Surfactant Replacement Therapy
1.4.3 Oxygen Therapy
1.4.4 Supportive Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bronchopulmonary Dysplasia Market Share by Application (2014-2025)
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Bronchopulmonary Dysplasia Market Size
2.2 Bronchopulmonary Dysplasia Growth Trends by Regions
2.2.1 Bronchopulmonary Dysplasia Market Size by Regions (2014-2025)
2.2.2 Bronchopulmonary Dysplasia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Bronchopulmonary Dysplasia Market Size by Manufacturers
3.1.1 Global Bronchopulmonary Dysplasia Revenue by Manufacturers (2014-2019)
3.1.2 Global Bronchopulmonary Dysplasia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bronchopulmonary Dysplasia Market Concentration Ratio (CR5 and HHI)
3.2 Bronchopulmonary Dysplasia Key Players Head office and Area Served
3.3 Key Players Bronchopulmonary Dysplasia Product/Solution/Service
3.4 Date of Enter into Bronchopulmonary Dysplasia Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Bronchopulmonary Dysplasia Market Size by Type (2014-2019)
4.2 Global Bronchopulmonary Dysplasia Market Size by Application (2014-2019)

5 United States
5.1 United States Bronchopulmonary Dysplasia Market Size (2014-2019)
5.2 Bronchopulmonary Dysplasia Key Players in United States
5.3 United States Bronchopulmonary Dysplasia Market Size by Type
5.4 United States Bronchopulmonary Dysplasia Market Size by Application

6 Europe
6.1 Europe Bronchopulmonary Dysplasia Market Size (2014-2019)
6.2 Bronchopulmonary Dysplasia Key Players in Europe
6.3 Europe Bronchopulmonary Dysplasia Market Size by Type
6.4 Europe Bronchopulmonary Dysplasia Market Size by Application

7 China
7.1 China Bronchopulmonary Dysplasia Market Size (2014-2019)
7.2 Bronchopulmonary Dysplasia Key Players in China
7.3 China Bronchopulmonary Dysplasia Market Size by Type
7.4 China Bronchopulmonary Dysplasia Market Size by Application

8 Japan
8.1 Japan Bronchopulmonary Dysplasia Market Size (2014-2019)
8.2 Bronchopulmonary Dysplasia Key Players in Japan
8.3 Japan Bronchopulmonary Dysplasia Market Size by Type
8.4 Japan Bronchopulmonary Dysplasia Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Bronchopulmonary Dysplasia Market Size (2014-2019)
9.2 Bronchopulmonary Dysplasia Key Players in Southeast Asia
9.3 Southeast Asia Bronchopulmonary Dysplasia Market Size by Type
9.4 Southeast Asia Bronchopulmonary Dysplasia Market Size by Application

10 India
10.1 India Bronchopulmonary Dysplasia Market Size (2014-2019)
10.2 Bronchopulmonary Dysplasia Key Players in India
10.3 India Bronchopulmonary Dysplasia Market Size by Type
10.4 India Bronchopulmonary Dysplasia Market Size by Application

11 Central & South America
11.1 Central & South America Bronchopulmonary Dysplasia Market Size (2014-2019)
11.2 Bronchopulmonary Dysplasia Key Players in Central & South America
11.3 Central & South America Bronchopulmonary Dysplasia Market Size by Type
11.4 Central & South America Bronchopulmonary Dysplasia Market Size by Application

12 International Players Profiles
12.1 Chiesi Farmaceutici
12.1.1 Chiesi Farmaceutici Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bronchopulmonary Dysplasia Introduction
12.1.4 Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.1.5 Chiesi Farmaceutici Recent Development
12.2 Discovery Laboratories
12.2.1 Discovery Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bronchopulmonary Dysplasia Introduction
12.2.4 Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.2.5 Discovery Laboratories Recent Development
12.3 Takeda Pharmaceutical Company
12.3.1 Takeda Pharmaceutical Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bronchopulmonary Dysplasia Introduction
12.3.4 Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.3.5 Takeda Pharmaceutical Company Recent Development
12.4 MediPost
12.4.1 MediPost Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bronchopulmonary Dysplasia Introduction
12.4.4 MediPost Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.4.5 MediPost Recent Development
12.5 Clarassance
12.5.1 Clarassance Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bronchopulmonary Dysplasia Introduction
12.5.4 Clarassance Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.5.5 Clarassance Recent Development
12.6 Syntrix Biosystems
12.6.1 Syntrix Biosystems Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bronchopulmonary Dysplasia Introduction
12.6.4 Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.6.5 Syntrix Biosystems Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details